Cover Image

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial

Background: Mizoribine (MZR) is an immunosuppressive drug used in Japan for treating patients with lupus nephritis and nephrotic syndrome and has been also reportedly effective in patients with immunoglobulin A (IgA) nephropathy. However, to date, few randomized control studies of MZR are performed...

Full description

Saved in:
Bibliographic Details
Main Authors: Keiji Hirai (Author), Susumu Ookawara (Author), Taisuke Kitano (Author), Haruhisa Miyazawa (Author), Kiyonori Ito (Author), Yuichirou Ueda (Author), Yoshio Kaku (Author), Taro Hoshino (Author), Honami Mori (Author), Izumi Yoshida (Author), Kenji Kubota (Author), Yasuyoshi Yamaji (Author), Tetsuro Takeda (Author), Yoshikazu Nakamura (Author), Kaoru Tabei (Author), Yoshiyuki Morishita (Author)
Format: Book
Published: The Korean Society of Nephrology, 2017-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items